Back to Dashboard
PSNL · Healthcare

Personalis Inc

USA Healthcare Filing: 2026-06-30
19/100
Smart-money confidence1 of 3 sources positive
Bottom band — money moving out

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 0–25 beat the S&P 500 over the next three months 39.9% of the time, across 100,496 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
25
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$1.8B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGM
About PERSONALIS INC

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a…

Who's behind the signal
Every informed buyer we can see on PSNL, across all three feeds.
Hedge funds · 5
Citadel Advisors New position
ARK Invest (Cathie Wood) Increased +4%
AQR Capital Management Decreased −32%
Congress · 1
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 3 on record
Disclosures from 2020-02-14 to 2020-05-19
The newest disclosure we hold for this stock is 2020-05-19. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2020-05-19 Brian J. Mast · R-FL House Sold $15,001 - $50,000
2020-04-22 Brian J. Mast · R-FL House Sold $1,001 - $15,000
2020-02-14 Brian J. Mast · R-FL House Bought $15,001 - $50,000
Not a model pick — but on our radar. PERSONALIS INC isn't in the top-10 model right now, but 5 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
5
Investors
1
New positions
3
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to PERSONALIS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell PERSONALIS INC or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime